Collagenik
Natural health product licensed in Canada
- Other names
- Syner Collagen
- Licence holder
- ATP ATHLÉTIQUE ET THÉRAPEUTIQUE PHARMA INC. ou ATP ATHLETIC AND THERAPEUTIC PHARMA INC.
- NPN or DIN-HM
- 80092824
- Status
- Active licence
- Licence date
- 12 June 2019
- Revision date
- 6 December 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 250.02 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Ascorbate de sodium | 41.67 mg | 250,020 µg |
| Collagen de type II non dénaturé Source : Collagen de type II non dénaturé Potency : 25 % Bioactive undenatured type II collagen | 6.67 mg | Not calculated |
| Collagène hydrolysé Source : Bovin - peau | 416.67 mg | Not calculated |
| Cervus elaphus Source : Ramure non ossifiée | 33.33 mg | Not calculated |
| Cuivre Source : Chélate d'acide aminé de cuivre | 83.33 mcg | 499.98 µg |
| Bambusa vulgaris Source : Pousse | 8.33 mg | Not calculated |
| Centella asiatica Source : Plante entière | 83.33 mg | Not calculated |
| Membrane de coquille d'oeuf de poule partiellement hydrolysée Source : Gallus gallus - Coquille d'oeuf | 83.33 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropylméthylcellulose, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 3 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce joint pain associated with osteoarthritis. Helps to produce and repair connective tissue. Helps to form red blood cells. A factor in the maintenance of good health. Helps to maintain the body's ability to metabolize nutrients. Helps in wound healing and connective tissue formation. Source of/An antioxidant that helps fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. Helps (to) maintain/support immune function. NEM helps provide relief from joint pain due to moderate intensity aerobic exercise (as quick as the first day) NEM helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise. NEM is clinically proven to reduce joint pain in 7 to 10 days - NEM helps reduce joint pain and stiffness NEM increase joint flexibility NEM starts to reduce joint pain due to moderate intensity aerobic exercise in as little/as quickly as 1 day and joint stiffness in as little/as quickly as 5 days
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80092824
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging